Breaking News Instant updates and real-time market news.

2018-08-15 06:48:14 IBB iShares Nasdaq Biotechnology Index $117.24 0.7 (0.60%) 06:48 08/15/18 08/15 06:48 08/15/18 06:48	iShares Nasdaq Biotechnology Index: Pivot points, pivot low broken The following are the pivot points for the iShares Nasdaq Biotechnology Index (IBB). Pivot High: $118.055, Pivot Low: $116.915. These were calculated using the DeMark method. It is generally believed to be bullish when price breaks out above the pivot high or bearish when price breaks down below the pivot low. At time of writing, price had fallen below the pivot low.
IBB iShares Nasdaq Biotechnology Index $117.24 0.7 (0.60%) 11/14/17 CANT 11/14/17 NO CHANGE Target $31 CANT Overweight Cantor sees TherapeuticsMD being added to Biotechnology Index on Dec. 15 Cantor Fitzgerald's Tracker Quants team predicts TherapeuticsMD (TXMD) will be added to the Nasdaq Biotechnology Index (IBB) on December 15 and that passive trackers will need to buy 34.5M shares of the company. This may provide additional share upside in the short term, Cantor analyst William Tanner tells investors in a research note. He reiterates an Overweight rating on TherapeuticsMD while trimming his price target for the shares to $31 from $32. The women's healthcare company closed yesterday up 23c to $5.90. Tanner continues to believe TherapeuticsMD's TX-004 will be an important new therapy for vulvar vaginal atrophy. 04/02/18 JEFF 04/02/18 NO CHANGE JEFF Buy Alnylam weakness on Pfizer data a buying opportunity, says Jefferies Jefferies analyst Maury Raycroft noted that Alnylam (ALNY) fell by over 8% on Thursday after Pfizer (PFE) announced that the phase 3 ATTR-ACT trial assessing tafamidis in TTR-CM met its primary endpoint and that Alnylam shares are trailing the iShares Nasdaq Biotechnology Index (IBB) again today. While he thinks the tafamidis data provide important clinical outcome results that support the need for treatment and benefit in TTR-CM, he also continues to believe the benefits of knocking down/depleting TTR in earlier-stage patients, as Alnylam's patisiran is meant to do, will lead to better objective improvements, Raycroft tells investors. The analyst, who recommends investors buy Alnylam amid the weakness, keeps a Buy rating on the stock.

2018-08-15 06:48:14

IBB

iShares Nasdaq Biotechnology Index

$117.24: 0.7 (0.60%)

06:48

08/15/18

08/15

06:48

08/15/18

06:48

iShares Nasdaq Biotechnology Index: Pivot points, pivot low broken

The following are the pivot points for the iShares Nasdaq Biotechnology Index (IBB). Pivot High: $118.055, Pivot Low: $116.915. These were calculated using the DeMark method. It is generally believed to be bullish when price breaks out above the pivot high or bearish when price breaks down below the pivot low. At time of writing, price had fallen below the pivot low.

IBB iShares Nasdaq Biotechnology Index

$117.24: 0.7 (0.60%)

11/14/17: CANT

04/02/18: JEFF

TODAY'S FREE FLY STORIES

PBI Pitney Bowes $7.02 (0.00%) , Z Zillow $35.03 (0.00%) … 09:40 02/22/19 02/22 09:40 02/22/19 09:40 Options	Unusually active option classes on open February 22nd » Unusual total active… PBI Pitney Bowes $7.02 (0.00%) Z Zillow $35.03 (0.00%) DBX Dropbox $25.58 (0.00%) W Wayfair $117.14 (0.00%) ROKU Roku $51.47 (0.00%) BIDU Baidu $171.72 (0.00%) IQ iQIYI $22.76 (0.00%) MDLZ Mondelez $48.39 (0.00%) NEM Newmont Mining $35.39 (0.00%) NIO NIO Inc. $7.62 (0.00%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	22 Feb 25 Feb 25 Feb 28 Feb 03 Mar 05 Mar 06 Mar 06 Mar 07 Mar 11 Mar 20 Mar 25 Mar 28 Mar 28 May
SID CSN 09:38 02/22/19 02/22 09:38 02/22/19 09:38 Upgrade	CSN rating change » CSN upgraded to Buy from… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
KHC Kraft Heinz $48.19 -0.05 (-0.10%) 09:38 02/22/19 02/22 09:38 02/22/19 09:38 Downgrade	Kraft Heinz rating change » Kraft Heinz downgraded to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
FEYE FireEye $16.56 -0.105 (-0.63%) 09:37 02/22/19 02/22 09:37 02/22/19 09:37 Conference/Events	House Committee on Homeland Security to hold a hearing » The Cybersecurity,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	25 Feb 25 Feb 26 Feb 26 Feb 04 Mar 05 Mar
MGLN Magellan Health $70.81 -1.6 (-2.21%) 09:36 02/22/19 02/22 09:36 02/22/19 09:36 Hot Stocks	Magellan Health says will consider Starboard Value director nominees » Magellan Health… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	28 Feb

EHTH eHealth $65.58 -0.28 (-0.43%) 09:36 02/22/19 02/22 09:36 02/22/19 09:36 Recommendations	eHealth analyst commentary » eHealth price target… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	27 Mar
NXTM NxStage Medical $30.00 0.005 (0.02%) , FMS Fresenius Medical $39.83 -0.06 (-0.15%) 09:33 02/22/19 02/22 09:33 02/22/19 09:33 Hot Stocks	NxStage Medical takeover by Fresenius Medical effective Feb. 21 » NxStage Medical (NXTM)… NXTM NxStage Medical $30.00 0.005 (0.02%) FMS Fresenius Medical $39.83 -0.06 (-0.15%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	12 Mar
KHC Kraft Heinz $48.19 -0.05 (-0.10%) 09:33 02/22/19 02/22 09:33 02/22/19 09:33 Downgrade	Kraft Heinz rating change » Kraft Heinz downgraded to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
WEN Wendy's $17.76 0.12 (0.68%) 09:31 02/22/19 02/22 09:31 02/22/19 09:31 Recommendations	Wendy's analyst commentary » Wendy's shares… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	06 Mar
ROKU Roku $51.47 -2.16 (-4.03%) 09:31 02/22/19 02/22 09:31 02/22/19 09:31 Recommendations	Roku analyst commentary » Roku price target raised… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

MOS Mosaic $33.17 -0.29 (-0.87%) 09:30 02/22/19 02/22 09:30 02/22/19 09:30 Downgrade	Mosaic rating change » Mosaic downgraded to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	26 Feb 28 Mar 28 May
BJRI BJ's Restaurants $51.97 0.75 (1.46%) 09:28 02/22/19 02/22 09:28 02/22/19 09:28 Recommendations	BJ's Restaurants analyst commentary » BJ's Restaurants… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
TTD Trade Desk $150.18 0.07 (0.05%) 09:25 02/22/19 02/22 09:25 02/22/19 09:25 Recommendations	Trade Desk analyst commentary » Trade Desk price target… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	06 Mar 06 Mar
VZ Verizon $56.14 0.35 (0.63%) 09:25 02/22/19 02/22 09:25 02/22/19 09:25 Recommendations	Verizon analyst commentary » 5G financial impact… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	25 Feb 03 Mar 03 Mar 11 Mar
GBT Global Blood Therapeutics $50.04 -0.45 (-0.89%) 09:25 02/22/19 02/22 09:25 02/22/19 09:25 Conference/Events	Global Blood Therapeutics participates in a conference call with JPMorgan » Biotech Analyst Kasimov… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	22 Feb

09:25 02/22/19 02/22 09:25 02/22/19 09:25 Conference/Events	UBS services analyst to hold an analyst/industry conference call » Services Analyst Geiger,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial
09:25 02/22/19 02/22 09:25 02/22/19 09:25 Conference/Events	UBS technology analyst to hold an analyst/industry conference call » Technology Analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
EXPGY Experian $0.00 (0.00%) , EFX Equifax $110.51 2.61 (2.42%) … 09:24 02/22/19 02/22 09:24 02/22/19 09:24 Conference/Events	House Financial Services Committee to hold a hearing » The Committee holds a… EXPGY Experian $0.00 (0.00%) EFX Equifax $110.51 2.61 (2.42%) TRU TransUnion $63.16 0.2 (0.32%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	26 Feb
QTS QTS Realty Trust $43.52 -0.78 (-1.76%) 09:21 02/22/19 02/22 09:21 02/22/19 09:21 Hot Stocks	QTS Realty Trust raises quarterly dividend to 44c from 41c per share » Payable on April 4 to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	25 Feb 26 Feb 11 Mar 09 May
DDAIF Daimler AG $0.00 (0.00%) , PCAR Paccar $69.18 0.17 (0.25%) … 09:20 02/22/19 02/22 09:20 02/22/19 09:20 Hot Stocks	EU commercial vehicle registrations up 6.2% in January » In January, the EU market… DDAIF Daimler AG $0.00 (0.00%) PCAR Paccar $69.18 0.17 (0.25%) CNHI CNH Industrial $10.67 0.04 (0.38%) NAV Navistar $37.95 0.3697 (0.98%) CMI Cummins $154.05 -0.18 (-0.12%) ALSN Allison Transmission $49.66 0.07 (0.14%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	26 Feb

ANIK Anika Therapeutics $40.45 0.45 (1.13%) 09:18 02/22/19 02/22 09:18 02/22/19 09:18 Recommendations	Anika Therapeutics analyst commentary » Anika Therapeutics price… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
PDCE PDC Energy $38.74 -0.51 (-1.30%) 09:18 02/22/19 02/22 09:18 02/22/19 09:18 Hot Stocks	PDC Energy issues statement on Kimmeridge 13D filing » PDC Energy issued the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	28 Feb
SPX S&P 500 $0.00 (0.00%) 09:18 02/22/19 02/22 09:18 02/22/19 09:18 Options	Overnight activity included 196 trades in SPX » 196 trades were executed… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
OLED Universal Display $118.31 -0.57 (-0.48%) 09:17 02/22/19 02/22 09:17 02/22/19 09:17 Recommendations	Universal Display analyst commentary » Universal Display price… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
CAT Caterpillar $138.85 -1.44 (-1.03%) , XRX Xerox $31.34 0.47 (1.52%) 09:16 02/22/19 02/22 09:16 02/22/19 09:16 Periodicals	EU may retaliate against Caterpillar, Xerox 'if Trump hits cars,' Bloomberg says » According to a report out… CAT Caterpillar $138.85 -1.44 (-1.03%) XRX Xerox $31.34 0.47 (1.52%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

Events

Earnings calls, analyst events, roadshows and more

LNT
Today at 10:00

Alliant Energy - LNT Conference Calls
ADSW
Today at 10:00

Advanced Disposal Services - ADSW Conference Calls
ECOL
Today at 10:00

US Ecology - ECOL Conference Calls
ETM
Today at 10:00

Entercom - ETM Conference Calls
COT
Today at 10:00

Cott Corp. - COT Conference Calls
PBA
Today at 10:00

Pembina Pipeline - PBA Conference Calls
EVRG
Today at 10:00

Evergy - EVRG Conference Calls
ORC
Today at 10:00

Orchid Island Capital - ORC Conference Calls
AEGN
Today at 10:00

Aegion - AEGN Conference Calls
GBT
Today at 10:00

Global Blood Therapeutics - GBT Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	AI X AI Arlington Asset Investment Spot Secondary Managers: Morgan Stanley & JMP Securities Priced at: $8.33 6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ARR X ARR ARMOUR Residential Spot Secondary Managers: Morgan Stanley & Barclays, Citi, Credit Suisse, Goldman Sachs & JPMorgan Priced at: $20.33 7.2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CPT X CPT Camden Property Spot Secondary Managers: BofA/Merrill & Deutsche Bank Priced at: $97.85 3.375M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial NRZ X NRZ New Residential Spot Secondary Managers: Morgan Stanley, Credit Suisse & JPMorgan Priced at: $16.50 40.3M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial OVID X OVID Ovid Therapeutics Spot Secondary Managers: Cowen & William Blair Priced at: $2.00 12.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SNNA X SNNA Sienna Biopharmaceuticals Spot Secondary Managers: Cowen & BMO Capital Priced at: $2.50 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	RWLK X RWLK ReWalk Robotics Spot Secondary Managers: H.C. Wainwright Priced at: $.23 19M Shares
Thurs	ACAM X ACAM Acamar Partners IPO Managers: Goldman Sachs & Deutsche Bank Priced at: $10.00 30M Shares TRIL X TRIL Trillium Therapeutics Spot Secondary Managers: Cowen Priced at: $.80 18.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

iShares Nasdaq Biotechnology Index: Pivot points, pivot low broken

TODAY'S FREE FLY STORIES

Get Full Fly Access